Tab Block and Patient Controlled Analgesia in CS

May 21, 2021 updated by: Aljazeera Hospital

Effect of Tab Block and Patient Controlled Analgesia in Cesarean Section

cesarean section rate become increasing nowadays

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

indication of cesarean section are different from case to case and the use of pain controlling agents is very important to relieve post operative pain

Study Type

Interventional

Enrollment (Actual)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Giza, Egypt
        • Aljazeera( Al Gazeera) hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 42 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • women coming for an elective CS

Exclusion Criteria:

  • women who has a n emergency CS or complicated normal deivery needs urgent CS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: giving tab block
giving patients tab block
Drug: tab block
injection of tab block to women who are doing cs
Drug: women who will not receive tab block or PCA
no tab block or PCA will be given
ACTIVE_COMPARATOR: giving PCA
Giving PCA to patients
Drug: women who will not receive tab block or PCA
no tab block or PCA will be given
Drug: PCA
giving women PCA
NO_INTERVENTION: Patients who will not receive PCA or tab block
No tab block or PCA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of women who will feel less pain post CS
Time Frame: 2 days
the degree of pain that will be felt post CS
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aljazeera Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 28, 2020

Primary Completion (ACTUAL)

March 15, 2021

Study Completion (ACTUAL)

April 1, 2021

Study Registration Dates

First Submitted

May 23, 2020

First Submitted That Met QC Criteria

May 23, 2020

First Posted (ACTUAL)

May 28, 2020

Study Record Updates

Last Update Posted (ACTUAL)

May 25, 2021

Last Update Submitted That Met QC Criteria

May 21, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • tab block

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on tab block

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe